The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer

The Pharmacogenomics Journal, Published online: 01 March 2021; doi:10.1038/s41397-021-00220-0The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer

Source: The Pharmacogenomics Journal - March 1, 2021 Category: Drugs & Pharmacology Authors: Masaki Shiota Shusuke Akamatsu Shintaro Narita Takayuki Sumiyoshi Maki Fujiwara Takeshi Uchiumi Osamu Ogawa Tomonori Habuchi Masatoshi Eto Source Type: research